SYNT - Ticker AI Digest

Synthomer plc 📰 3
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (SYNT) 3
SYNT 10:58
Synthomer plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of ordinary shares of 1 pence each in Synthomer plc
SYNT 10:01
Synthomer plc
Directorate Change
SYNT 06:01
Synthomer plc
Interim results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Synthomer PLC Interim Results for H1 2025**
Synthomer PLC, a leading supplier of specialized polymers and ingredients, reported its interim results for the six months ended June 30, 2025, highlighting continued earnings growth despite subdued market conditions. Key points from the report include
### **Financial Performance**
**Revenue**Declined by 9.8% to £925.2 million (H1 2024: £1,025.6 million), with a constant currency decline of 8.8%, primarily due to lower volumes and raw material price pass-throughs.
**EBITDA**Increased by 4.1% to £77.8 million (H1 2024: £74.7 million), with a constant currency growth of 5.4%, driven by self-help actions and cost efficiencies.
**EBITDA Margin**Improved to 8.4% from 7.3% in H1 2024, reflecting better cost management.
**Underlying Operating Profit (EBIT)**Rose slightly by 0.4% to £28.3 million (H1 2024: £28.2 million).
**Statutory Operating Loss (EBIT)**Narrowed to £1.0 million (H1 2024: £2.9 million loss).
**Net Debt**Increased to £638.3 million (H1 2024: £560.6 million) due to seasonal cash flow patterns and capital expenditure.
### **Divisional Performance**
**Coatings & Construction Solutions (CCS)**: Revenue declined by 13.5% to £372.5 million, with EBITDA down 34.9% to £34.5 million, impacted by lower oil and gas drilling activity.
**Adhesive Solutions (AS)**Revenue decreased by 3.3% to £298.4 million, but EBITDA surged by 61.6% to £35.4 million, driven by cost efficiency and reliability improvements.
**Health & Protection and Performance Materials (HPPM)**: Revenue fell by 11.2% to £254.3 million, with EBITDA up 23.0% to £16.6 million, benefiting from favorable mix and cost reductions.
### **Strategic Initiatives**
**Portfolio Transformation**Completed the divestment of William Blythe in May 2025, reducing the global manufacturing footprint to <mark style="background-color:yellow">below</mark> 30 sites (from 43 in 2022).
**Cost Reduction**Implemented a £20-25 million cost reduction program, expected to deliver £9 million in benefits in H2 2025.
**Innovation**Launched new specialty adhesive investments in the US and expanded partnerships for medical glove technology.
### **Market Conditions**
**Tariff Impact**Limited direct exposure to new tariffs, but increased customer demand volatility in Q2, improving in June.
**End-Market Demand**Subdued due to trade tensions, with volumes down 7.1% compared to H1 2024.
### **Outlook**
**2025 Expectations**Some earnings progress and broadly neutral Free Cash Flow, supported by self-help actions and strategic benefits.
**Medium-Term Goal**Aim to double recent earnings levels through self-help, volume recovery, and strategic execution.
### **CEO Commentary**
CEO Michael Willome emphasized the company’s resilience in challenging markets, highlighting the success of self-help actions and strategic portfolio adjustments. He reaffirmed confidence in achieving medium-term earnings growth despite near-term uncertainties.
### **Key Metrics**
**Free Cash Flow**Negative £30.3 million (H1 2024: Negative £31.2 million), with expectations of positive cash flow in H2.
**Net Debt to EBITDA Ratio**Increased to 4.8x (H1 2024: 4.6x), within covenant limits.
Synthomer remains focused on derisking its balance sheet, advancing its specialty strategy, and prioritizing sustainable growth opportunities.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
SYNT 10:58
Synthomer plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of ordinary shares of 1 pence each in Synthomer plc
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
SYNT 06:01
Synthomer plc
Interim results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Synthomer PLC Interim Results for H1 2025**
Synthomer PLC, a leading supplier of specialized polymers and ingredients, reported its interim results for the six months ended June 30, 2025, highlighting continued earnings growth despite subdued market conditions. Key points from the report include
### **Financial Performance**
**Revenue**Declined by 9.8% to £925.2 million (H1 2024: £1,025.6 million), with a constant currency decline of 8.8%, primarily due to lower volumes and raw material price pass-throughs.
**EBITDA**Increased by 4.1% to £77.8 million (H1 2024: £74.7 million), with a constant currency growth of 5.4%, driven by self-help actions and cost efficiencies.
**EBITDA Margin**Improved to 8.4% from 7.3% in H1 2024, reflecting better cost management.
**Underlying Operating Profit (EBIT)**Rose slightly by 0.4% to £28.3 million (H1 2024: £28.2 million).
**Statutory Operating Loss (EBIT)**Narrowed to £1.0 million (H1 2024: £2.9 million loss).
**Net Debt**Increased to £638.3 million (H1 2024: £560.6 million) due to seasonal cash flow patterns and capital expenditure.
### **Divisional Performance**
**Coatings & Construction Solutions (CCS)**: Revenue declined by 13.5% to £372.5 million, with EBITDA down 34.9% to £34.5 million, impacted by lower oil and gas drilling activity.
**Adhesive Solutions (AS)**Revenue decreased by 3.3% to £298.4 million, but EBITDA surged by 61.6% to £35.4 million, driven by cost efficiency and reliability improvements.
**Health & Protection and Performance Materials (HPPM)**: Revenue fell by 11.2% to £254.3 million, with EBITDA up 23.0% to £16.6 million, benefiting from favorable mix and cost reductions.
### **Strategic Initiatives**
**Portfolio Transformation**Completed the divestment of William Blythe in May 2025, reducing the global manufacturing footprint to <mark style="background-color:yellow">below</mark> 30 sites (from 43 in 2022).
**Cost Reduction**Implemented a £20-25 million cost reduction program, expected to deliver £9 million in benefits in H2 2025.
**Innovation**Launched new specialty adhesive investments in the US and expanded partnerships for medical glove technology.
### **Market Conditions**
**Tariff Impact**Limited direct exposure to new tariffs, but increased customer demand volatility in Q2, improving in June.
**End-Market Demand**Subdued due to trade tensions, with volumes down 7.1% compared to H1 2024.
### **Outlook**
**2025 Expectations**Some earnings progress and broadly neutral Free Cash Flow, supported by self-help actions and strategic benefits.
**Medium-Term Goal**Aim to double recent earnings levels through self-help, volume recovery, and strategic execution.
### **CEO Commentary**
CEO Michael Willome emphasized the company’s resilience in challenging markets, highlighting the success of self-help actions and strategic portfolio adjustments. He reaffirmed confidence in achieving medium-term earnings growth despite near-term uncertainties.
### **Key Metrics**
**Free Cash Flow**Negative £30.3 million (H1 2024: Negative £31.2 million), with expectations of positive cash flow in H2.
**Net Debt to EBITDA Ratio**Increased to 4.8x (H1 2024: 4.6x), within covenant limits.
Synthomer remains focused on derisking its balance sheet, advancing its specialty strategy, and prioritizing sustainable growth opportunities.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 3
SYNT 10:58
Synthomer plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of ordinary shares of 1 pence each in Synthomer plc
SYNT 10:01
Synthomer plc
Directorate Change
SYNT 06:01
Synthomer plc
Interim results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Synthomer PLC Interim Results for H1 2025**
Synthomer PLC, a leading supplier of specialized polymers and ingredients, reported its interim results for the six months ended June 30, 2025, highlighting continued earnings growth despite subdued market conditions. Key points from the report include
### **Financial Performance**
**Revenue**Declined by 9.8% to £925.2 million (H1 2024: £1,025.6 million), with a constant currency decline of 8.8%, primarily due to lower volumes and raw material price pass-throughs.
**EBITDA**Increased by 4.1% to £77.8 million (H1 2024: £74.7 million), with a constant currency growth of 5.4%, driven by self-help actions and cost efficiencies.
**EBITDA Margin**Improved to 8.4% from 7.3% in H1 2024, reflecting better cost management.
**Underlying Operating Profit (EBIT)**Rose slightly by 0.4% to £28.3 million (H1 2024: £28.2 million).
**Statutory Operating Loss (EBIT)**Narrowed to £1.0 million (H1 2024: £2.9 million loss).
**Net Debt**Increased to £638.3 million (H1 2024: £560.6 million) due to seasonal cash flow patterns and capital expenditure.
### **Divisional Performance**
**Coatings & Construction Solutions (CCS)**: Revenue declined by 13.5% to £372.5 million, with EBITDA down 34.9% to £34.5 million, impacted by lower oil and gas drilling activity.
**Adhesive Solutions (AS)**Revenue decreased by 3.3% to £298.4 million, but EBITDA surged by 61.6% to £35.4 million, driven by cost efficiency and reliability improvements.
**Health & Protection and Performance Materials (HPPM)**: Revenue fell by 11.2% to £254.3 million, with EBITDA up 23.0% to £16.6 million, benefiting from favorable mix and cost reductions.
### **Strategic Initiatives**
**Portfolio Transformation**Completed the divestment of William Blythe in May 2025, reducing the global manufacturing footprint to <mark style="background-color:yellow">below</mark> 30 sites (from 43 in 2022).
**Cost Reduction**Implemented a £20-25 million cost reduction program, expected to deliver £9 million in benefits in H2 2025.
**Innovation**Launched new specialty adhesive investments in the US and expanded partnerships for medical glove technology.
### **Market Conditions**
**Tariff Impact**Limited direct exposure to new tariffs, but increased customer demand volatility in Q2, improving in June.
**End-Market Demand**Subdued due to trade tensions, with volumes down 7.1% compared to H1 2024.
### **Outlook**
**2025 Expectations**Some earnings progress and broadly neutral Free Cash Flow, supported by self-help actions and strategic benefits.
**Medium-Term Goal**Aim to double recent earnings levels through self-help, volume recovery, and strategic execution.
### **CEO Commentary**
CEO Michael Willome emphasized the company’s resilience in challenging markets, highlighting the success of self-help actions and strategic portfolio adjustments. He reaffirmed confidence in achieving medium-term earnings growth despite near-term uncertainties.
### **Key Metrics**
**Free Cash Flow**Negative £30.3 million (H1 2024: Negative £31.2 million), with expectations of positive cash flow in H2.
**Net Debt to EBITDA Ratio**Increased to 4.8x (H1 2024: 4.6x), within covenant limits.
Synthomer remains focused on derisking its balance sheet, advancing its specialty strategy, and prioritizing sustainable growth opportunities.

AI Crunch

Single-Ticker AI Crunch
SYNT signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Synthomer plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full SYNT AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for SYNT on 2025-08-05.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
44791080
Enterprise Value
1768242215
Public Float
72.53
Broker Target
127.25
Shares Out
163471105
Long Interest
92
Short Interest
8
Exchange
LSE
Currency Code
GBX
ISIN
GB00BNTVWJ75
Market
LSE - MAIN MARKET
Sector
Chemicals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2022-10-06
Earnings Date
2026-03-26
Net Debt
652900000.0
Cash
225800000.0
EPS
-0.46
Net Income
-72600000.0
Revenue
1986800000.0
Enterprise Value
1768242215
Trailing PE
-
Forward PE
21.7391
Price Sales TTM
0.0237
Price Book MRQ
0.0416
EV Revenue
0.3897
EV EBITDA
8.5284

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
19.656
Institutions As Of
2026-01-27
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
5
Sale Director Dealing
0
Purchase TR1
5
Sale TR1
5
Broker Coverage Rows
18
Institution Holders Tracked
4
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

3 live catalysts just hit SYNT.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-08-05 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
3 Today
Catalyst Pulse
Synthomer plc has fresh news flow feeding the chart narrative.
10:01 Today's Catalyst Directorate Change
AI Charts Studio
SYNT Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-08-05 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast -21.41%
RSI Gauge
Price Change
AI Forecast